Journal of Surgical Research
Volume 146, Issue 1 , Pages 32-42, 1 May 2008

Prognostic Values of Matrix Metalloproteinase Family Expression in Human Colorectal Carcinoma

  • Toshimichi Asano, M.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
  • ,
  • Mitsuhiro Tada, M.D., Ph.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
  • ,
  • Shaoqiang Cheng, B.M.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
  • ,
  • Norihiro Takemoto, M.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
  • ,
  • Taro Kuramae, M.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
  • ,
  • Motoki Abe, M.D., Ph.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
  • ,
  • Osamu Takahashi, M.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
  • ,
  • Masaki Miyamoto, M.D.

      Affiliations

    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
  • ,
  • Jun-Ichi Hamada, Ph.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at at Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, N-15 W-7, Kita-Ku, Sapporo 060-0815, Japan.
  • ,
  • Tetsuya Moriuchi, M.D., Ph.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
  • ,
  • Satoshi Kondo, M.D., Ph.D.

      Affiliations

    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan

Received 16 January 2007 published online 02 June 2007.

Background

We examined expression patterns of matrix metalloproteinase (MMP), tissue inhibitor of metalloproteinase (TIMP), and reversion-inducing cysteine-rich protein with Kazal motifs (RECK) in colorectal cancer tissues to assess their prognostic significance.

Materials and methods

mRNA expressions of 17 MMPs, 4 TIMPs, and RECK were measured in 112 colorectal cancerous tissues, 20 normal mucosa tissues, and 11 metastatic liver lesions by real-time reverse-transcriptional-polymerase chain reaction. The protein level expressions were confirmed with immunohistochemistry.

Results

Cancers and normal mucosa displayed highly significant differences (P < 0.01) in expression of nine genes (MMP-1, -3, -7, -9, -10, -11, -12, -14, and RECK). Primary cancers and metastatic lesions showed highly significant differences (P < 0.01) in MMP-1, -10, -11, and TIMP-1. MMP-12 expression was higher in the primary tumors that were associated without hepatic metastasis than those with metastasis (P < 0.01). High expression of MMP-15 was related to longer disease-free survival (generalized Wilcoxon test, P < 0.0062; Cox hazard model, P < 0.028, hazard ratio, 0.099).

Conclusions

MMP, TIMP, RECK expression patterns may provide an insight into extracellular matrix degrading (which is characteristic of colorectal cancers) and its role in metastasis.

Key Words: matrix metalloproteinase (MMP)-15, colorectal cancer, hepatic metastasis, recurrence, prognosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-4804(07)00069-8

doi:10.1016/j.jss.2007.02.011

Journal of Surgical Research
Volume 146, Issue 1 , Pages 32-42, 1 May 2008